JANX - Janux Therapeutics, Inc.
IEX Last Trade
55.17
0.025 0.045%
Share volume: 12,908
Last Updated: Fri 27 Dec 2024 02:30:13 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$55.14
0.02
0.05%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-10 | 2023-03-10 | 2023-05-09 | 2023-08-08 | 2023-11-07 | 2024-03-08 | 2024-05-08 | |
| Total revenue | 2.365 M | 1.813 M | 2.845 M | 2.048 M | 1.057 M | 2.517 M | 2.461 M | 1.252 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 2.365 M | 1.813 M | 2.845 M | 2.048 M | 1.057 M | 2.517 M | 2.461 M | 1.252 M | |
| -23.34% | 56.92% | -28.01% | -48.39% | 138.13% | -2.22% | -49.13% | |||
| Operating expenses | 19.626 M | 19.835 M | 21.111 M | 22.329 M | 21.805 M | 18.330 M | 18.598 M | 21.413 M | |
| Selling general and admin | 5.540 M | 6.098 M | 5.677 M | 6.464 M | 6.881 M | 6.438 M | 6.357 M | 7.343 M | |
| Research and development | 14.086 M | 13.737 M | 15.434 M | 15.865 M | 14.924 M | 11.892 M | 12.241 M | 14.070 M | |
| Total expenses | 19.626 M | 19.835 M | 21.111 M | 22.329 M | 21.805 M | 18.330 M | 18.598 M | 21.413 M | |
| 1.06% | 6.43% | 5.77% | -2.35% | -15.94% | 1.46% | 15.14% | |||
| Operating income | -17.261 M | -18.022 M | -18.266 M | -20.281 M | -20.748 M | -15.813 M | -16.137 M | -20.161 M | |
| Ebit | -17.261 M | -18.022 M | -18.266 M | -20.281 M | -20.748 M | -15.813 M | -16.137 M | -20.161 M | |
| Pretax income | -16.888 M | -16.696 M | -16.065 M | -17.459 M | -17.508 M | -11.568 M | -11.758 M | -14.760 M | |
| -1.14% | -3.78% | 8.68% | 0.28% | -33.93% | 1.64% | 25.53% | |||
| Income tax | 340.000 K | 370.000 K | -2.277 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -17.228 M | -17.066 M | -13.788 M | -17.459 M | -17.508 M | -11.568 M | -11.758 M | -14.760 M | |
| 0.94% | 19.21% | -26.62% | -0.28% | 33.93% | -1.64% | -25.53% | |||
| Net income | -17.228 M | -17.066 M | -13.788 M | -17.459 M | -17.508 M | -11.568 M | -11.758 M | -14.760 M | |
| 0.94% | 19.21% | -26.62% | -0.28% | 33.93% | -1.64% | -25.53% |